Pizzorno G - Search Results

1

CD9, a tetraspanin target for cancer therapy?

Lorico A, Lorico-Rappa M, Karbanová J, Corbeil D, Pizzorno G. Lorico A, et al. Among authors: pizzorno g. Exp Biol Med (Maywood). 2021 May;246(9):1121-1138. doi: 10.1177/1535370220981855. Epub 2021 Feb 18. Exp Biol Med (Maywood). 2021. PMID: 33601913 Free PMC article. Review.

2

Molecular therapy for cancer.

Deisseroth A, Guo D, Wang T, Fujii T, Fu SQ, Cote R, Savinov S, Liu F, Loewe R, Pizzorno G, Austin D, Crystal R, Chung I. Deisseroth A, et al. Among authors: pizzorno g. Cancer J Sci Am. 1998 May;4 Suppl 1:S5-7. Cancer J Sci Am. 1998. PMID: 9619264 No abstract available.

3

The use of chemotherapy resistance in cancer treatment.

Deisseroth AB, Pizzorno G. Deisseroth AB, et al. Among authors: pizzorno g. Cancer J Sci Am. 1997 Mar-Apr;3(2):60-9. Cancer J Sci Am. 1997. PMID: 9099453 Review. No abstract available.

4

Results of retroviral and adenoviral approaches to cancer gene therapy.

Yin LH, Fu SQ, Nanakorn T, Garcia-Sanchez F, Chung I, Cote R, Pizzorno G, Hanania E, Heimfeld S, Crystal R, Deisseroth A. Yin LH, et al. Among authors: pizzorno g. Stem Cells. 1998;16 Suppl 1:247-50. doi: 10.1002/stem.5530160830. Stem Cells. 1998. PMID: 11012168 Review.

5

Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantation.

Garcia-Sanchez F, Pizzorno G, Fu SQ, Nanakorn T, Krause DS, Liang J, Adams E, Leffert JJ, Yin LH, Cooperberg MR, Hanania E, Wang WL, Won JH, Peng XY, Cote R, Brown R, Burtness B, Giles R, Crystal R, Deisseroth AB. Garcia-Sanchez F, et al. Among authors: pizzorno g. Blood. 1998 Jul 15;92(2):672-82. Blood. 1998. PMID: 9657770 Free article.

6

Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells.

Chung I, Schwartz PE, Crystal RG, Pizzorno G, Leavitt J, Deisseroth AB. Chung I, et al. Among authors: pizzorno g. Cancer Gene Ther. 1999 Mar-Apr;6(2):99-106. doi: 10.1038/sj.cgt.7700017. Cancer Gene Ther. 1999. PMID: 10195877

7

Multidrug Resistance and Prodrug Activation for Cancer Gene Therapy of Breast Cancer.

Fujii T, Fu SQ, Yin LH, Nanakorn T, Sanchez FG, Cooperberg M, Guo D, Wang T, D L, Pizzorno G, Deisseroth A. Fujii T, et al. Among authors: pizzorno g. Breast Cancer. 1997 Dec 25;4(4):210-212. doi: 10.1007/BF02966508. Breast Cancer. 1997. PMID: 11091601

8

The use of the L-plastin promoter for adenoviral-mediated, tumor-specific gene expression in ovarian and bladder cancer cell lines.

Peng XY, Won JH, Rutherford T, Fujii T, Zelterman D, Pizzorno G, Sapi E, Leavitt J, Kacinski B, Crystal R, Schwartz P, Deisseroth A. Peng XY, et al. Among authors: pizzorno g. Cancer Res. 2001 Jun 1;61(11):4405-13. Cancer Res. 2001. PMID: 11389068

9

Vector targeting makes 5-fluorouracil chemotherapy less toxic and more effective in animal models of epithelial neoplasms.

Akbulut H, Tang Y, Maynard J, Zhang L, Pizzorno G, Deisseroth A. Akbulut H, et al. Among authors: pizzorno g. Clin Cancer Res. 2004 Nov 15;10(22):7738-46. doi: 10.1158/1078-0432.CCR-04-0490. Clin Cancer Res. 2004. PMID: 15570008

10

Dose escalation and pharmacokinetic study of irinotecan in combination with paclitaxel in patients with advanced cancer.

Murren JR, Peccerillo K, DiStasio SA, Li X, Leffert JJ, Pizzorno G, Burtness BA, McKeon A, Cheng Y. Murren JR, et al. Among authors: pizzorno g. Cancer Chemother Pharmacol. 2000;46(1):43-50. doi: 10.1007/s002800000115. Cancer Chemother Pharmacol. 2000. PMID: 10912577 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page